Uncertainty about future attracts more attention to defensive sectors like health-care or consumer staples. I run fundamental stock screen for large cap health-care stocks with P/E below 15 and Price-Book Value below 4. Here is the list of potential value plays.
Ticker | Company Name | PEG | P/E | P/BV |
(UNH) | UNITEDHEALTH | 0.7 | 7.5 | 1.4 |
(WLP) | WELLPOINT | 0.65 | 7.7 | 1 |
(AET) | AETNA | 0.62 | 9.3 | 1.6 |
(NVS) | NOVARTIS | 2 | 9.8 | 2.3 |
(AZN) | ASTRAZENECA | 9.6 | 10.8 | 3.9 |
(LLY) | LILLY ELI CO | 1.65 | 11 | 3 |
(WYE) | WYETH | 3.61 | 11.1 | 2.5 |
(SNY) | SANOFI-AVENTIS | 2.83 | 12.1 | 1.4 |
(MRK) | MERCK | 1.58 | 13.2 | 3.2 |
(PFE) | PFIZER | 2.08 | 14.2 | 1.9 |
Hey Vlada,
I'm not familiar with the company, but based on the figures you posted AZN looks overvalued.
Do you think it's a good shorting opportunity after the next rally?
Hi D,
relatively AZN seems to be more overvaluated than others based on P/BV. But generally all these stocks at current prices I consider as a good long positions. My personal favorite is NVS. Solid growth and many projects submitted for regulatory approval.